TP53 and myeloproliferative disorder: 1×105 CD34+ cells from JAK2-mutant MPN patients or healthy donor (HD) BM were co-cultured for 12-days with 2×104 cord blood (CB)-derived CD34+ cells nucleofected with gRNAs targeting AAVS1, TET2 or TP53.